ArticleJournal of health monitoring2025
Parkinson disease - Prevalence, trends and regional patterns in Germany. An analysis based on routine data from the statutory health insurance.
Article in Journal of health monitoring, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Immersive virtual reality upper-limb exercises in people with Parkinson's disease: an observer-blinded randomised controlled trial.Journal of neuroengineering and rehabilitation · 2026Trial
- Protocol of the interdisciplinary and intersectoral randomized controlled trial in Parkinson patients in a specialized network in Germany: the INSPIRE Trial.Neurological research and practice · 2026Article
- Food-chain spirochetes: a unified hypothesis for Parkinson's disease and dementia risk.Frontiers in aging neuroscience · 2026Article
- German translation of the Characterizing Freezing of gait questionnaire: implementation of the TRAPD process.Journal of patient-reported outcomes · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: As part of the German Burden of Disease Study, population-based prevalences of important diseases are estimated. This allows regional patterns and temporal trends to be identified. Methods: The prevalence of Parkinson disease in the population was estimated cross-sectionally for the years 2017 to 2022 at the level of the Spatial Planning Regions using routine data of persons insured in the statutory health insurance AOK, adjusted for age, sex and morbidity (administrative prevalence). Results: In 2022, the prevalence of Parkinson disease in Germany was 0.35 % of the population. This represents approximately 295,000 people. The prevalence is 0.34 % in women and 0.36 % in men. The prevalence of Parkinson disease increases with age. It is 0.61 % from the age of 40 and 1.42 % from the age of 65. There is a slight downward trend over time. The age-standardised regional distribution shows no clear pattern. Conclusions: Measured by administrative prevalence, the significance of Parkinson disease for population health remains largely stable with a slight downward trend.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.